Two other families with familial partial lipodystrophy (FPLD) and cardiomyopathy with conduction system defects and proximal muscle weakness, caused by missense mutations in exon 1 of the LMNA gene, were described by Garg et al. (2002), although cardiac manifestation was not predominant in these cases. This evidence concerns the gene LMNA and cardiomyopathy.